ERYTECH Pharma S.A. logo
ERYTECH Pharma S.A. ERYP

Geschäftsbericht 2022
hinzugefügt 21.12.2024

report update icon

ERYTECH Pharma S.A. Operativer Cashflow 2011-2026 | ERYP

Operativer Cashflow Jährlich ERYTECH Pharma S.A.

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- -56.8 M -51.7 M -43.3 M -47.9 M -24.7 M -17.6 M - - - - -

Alle Zahlen in EUR-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
-17.6 M -56.8 M -40.3 M

Operativer Cashflow anderer Aktien in der Pharmaeinzelhändler

Name Operativer Cashflow Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
-481 M - 2.43 % $ 254 M germanyGermany
I-Mab I-Mab
IMAB
-1.3 B - - $ 866 M chinaChina
Genfit SA Genfit SA
GNFT
99.9 M - 2.54 % $ 160 B franceFrance
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
-284 M $ 1.34 -3.6 % $ 357 M britainBritain
Biophytis SA Biophytis SA
BPTS
-23.8 M - -13.47 % $ 169 M franceFrance
Midatech Pharma plc Midatech Pharma plc
MTP
-6.01 M - -18.52 % $ 27.3 M britainBritain
Acorda Therapeutics Acorda Therapeutics
ACOR
-14 M - -24.86 % $ 820 K usaUSA
DBV Technologies S.A. DBV Technologies S.A.
DBVT
-121 M $ 20.13 -1.13 % $ 2.81 B franceFrance
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
-12.3 M $ 3.65 1.3 % $ 8.78 B australiaAustralia
Advaxis Advaxis
ADXS
-29.5 M - -9.65 % $ 45.9 M usaUSA
Dyadic International Dyadic International
DYAI
-5.7 M $ 0.87 - $ 31.5 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
-92.5 M - - $ 86.2 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
-1.94 M $ 2.57 -3.57 % $ 16.1 M usaUSA
Equillium Equillium
EQ
-22.7 M $ 2.04 1.24 % $ 117 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-8.58 M - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
-18 M - -10.17 % $ 12.2 K usaUSA
Fate Therapeutics Fate Therapeutics
FATE
-106 M $ 1.13 -5.04 % $ 134 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
-169 M - - $ 1.01 B usaUSA
Forte Biosciences Forte Biosciences
FBRX
-50.9 M $ 26.57 0.49 % $ 344 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
-65.7 M - - $ 26.5 M usaUSA
Fennec Pharmaceuticals Fennec Pharmaceuticals
FENC
-12.5 M $ 6.14 -4.36 % $ 175 M usaUSA
Foghorn Therapeutics Foghorn Therapeutics
FHTX
-86.1 M $ 4.74 -2.87 % $ 299 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
22.7 M - 1.93 % $ 17.4 M usaUSA
Amicus Therapeutics Amicus Therapeutics
FOLD
33.1 M $ 14.46 0.03 % $ 4.46 B usaUSA
Aptose Biosciences Aptose Biosciences
APTO
-22 M - -45.71 % $ 1.2 M canadaCanada
Fulcrum Therapeutics Fulcrum Therapeutics
FULC
-60.1 M $ 7.55 -3.58 % $ 478 K usaUSA
Galectin Therapeutics Galectin Therapeutics
GALT
-23.9 M $ 2.25 -12.3 % $ 144 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
-230 M - - $ 3.67 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
-733 M - - $ 867 M germanyGermany
BioNTech SE BioNTech SE
BNTX
890 M $ 87.65 -3.98 % $ 27.2 B germanyGermany
Gilead Sciences Gilead Sciences
GILD
10 B $ 138.19 -1.38 % $ 172 B usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
-139 M $ 1.61 -3.59 % $ 189 M usaUSA
Akari Therapeutics, Plc Akari Therapeutics, Plc
AKTX
-10.6 M $ 3.5 -1.13 % $ 236 B britainBritain
Akouos Akouos
AKUS
-63.7 M - 0.23 % $ 488 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
-5.88 M $ 0.54 4.26 % $ 503 K israelIsrael
Genmab A/S Genmab A/S
GMAB
1.33 B $ 27.01 -2.67 % $ 17.2 B danmarkDanmark
Allakos Allakos
ALLK
-116 M - - $ 28.6 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
-45.7 M - 3.16 % $ 1.9 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
524 M $ 314.44 -4.81 % $ 41.2 B usaUSA
Gossamer Bio Gossamer Bio
GOSS
-171 M $ 0.32 -7.11 % $ 73.1 M usaUSA
Grifols, S.A. Grifols, S.A.
GRFS
597 M $ 7.91 -3.95 % $ 6.83 B spainSpain
Alpine Immune Sciences Alpine Immune Sciences
ALPN
-43.8 M - - $ 2.17 B usaUSA
GT Biopharma GT Biopharma
GTBP
-12.9 M $ 0.42 -6.49 % $ 2.32 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
-19.4 M - 10.36 % $ 9.8 M usaUSA
AlloVir AlloVir
ALVR
-38.4 M - 4.14 % $ 49.1 M usaUSA
Halozyme Therapeutics Halozyme Therapeutics
HALO
652 M $ 63.51 0.68 % $ 7.61 B usaUSA
Burford Capital Limited Burford Capital Limited
BUR
181 M $ 4.42 -1.34 % $ 727 M britainBritain